FDA Cites Manufacturing Issues for Cytisinicline - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Cites Manufacturing Issues for Cytisinicline

Application supported by Phase 3 smoking-cessation data and long-term safety findings.

  • By

  • Kathryn Wighton

  • June 22, 2026

  • 3 min

Share

Original Source(s)

FDA Cites Manufacturing Issues for Cytisinicline

  • by Kathryn Wighton

  • June 22, 2026

Related Content

Screening Eligibility and Survival Among Patients With Lung Cancer in Korea

NUT carcinoma may defy typical staining patterns

Two pulmonary cases highlight how limited squamous differentiation and variable keratin expression may complicate pathological diagnosis.

Top 10 evidence-based essentials in pulmonology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice.